Kevin McCague Selected Research

Oxcarbazepine (Trileptal)

11/2006	Efficacy, safety, and tolerability of oxcarbazepine monotherapy.
11/2006	Improved quality of life in patients with partial seizures after conversion to oxcarbazepine monotherapy.
7/2006	A double-blind, randomized, placebo-controlled trial of oxcarbazepine in the treatment of bipolar disorder in children and adolescents.
9/2003	Sustained efficacy and long-term safety of oxcarbazepine: one-year open-label extension of a study in refractory partial epilepsy.
4/2003	Safety and tolerability of oxcarbazepine in elderly patients with epilepsy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kevin McCague Research Topics

Disease

17	Heart Failure 01/2020 - 01/2018
5	Multiple Sclerosis 06/2016 - 07/2013
5	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 07/2013 - 01/2008
3	Fatigue 09/2014 - 07/2006
3	Seizures (Absence Seizure) 11/2006 - 04/2003
2	Infections 09/2014 - 07/2014
2	Headache (Headaches) 09/2014 - 01/2008
2	Dizziness (Lightheadedness) 07/2006 - 04/2003
2	Epilepsy (Aura) 07/2006 - 04/2003
2	Nausea 07/2006 - 04/2003
2	Sleepiness 07/2006 - 04/2003
1	Hypotension (Low Blood Pressure) 01/2019
1	Angioedema 01/2019
1	Hyperkalemia 01/2019
1	Chronic Renal Insufficiency 01/2018
1	Fibrosis (Cirrhosis) 01/2018
1	Cardiomyopathies (Cardiomyopathy) 01/2018
1	Ventricular Remodeling 01/2018
1	Weight Gain 12/2017
1	Neutropenia 07/2014
1	Parkinson Disease (Parkinson's Disease) 11/2011
1	Abdominal Pain (Pain, Abdominal) 01/2008
1	Exanthema (Rash) 07/2006
1	Bipolar Disorder (Manic Depressive Psychosis) 07/2006
1	Diplopia (Double Vision) 07/2006
1	Partial Epilepsies (Epilepsy, Partial) 09/2003
1	Hyponatremia 04/2003
1	Vomiting 04/2003

Drug/Important Bio-Agent (IBA)

13	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2020 - 01/2018
8	Neprilysin (Neutral Endopeptidase)IBA 01/2020 - 01/2018
7	Enalapril FDA LinkGeneric 01/2020 - 01/2018
5	Angiotensin Receptors (Angiotensin II Receptor)IBA 12/2019 - 01/2018
5	Fingolimod Hydrochloride (FTY720)FDA Link 06/2016 - 07/2013
5	Dexmethylphenidate Hydrochloride FDA LinkGeneric 07/2013 - 01/2008
5	Oxcarbazepine (Trileptal)FDA LinkGeneric 11/2006 - 04/2003
4	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2019 - 01/2018
4	Methylphenidate (Ritalin)FDA LinkGeneric 07/2013 - 01/2008
3	pro-brain natriuretic peptide (1-76)IBA 01/2020 - 01/2019
3	AngiotensinsIBA 01/2020 - 01/2019
3	Brain Natriuretic Peptide (Natrecor)FDA Link 09/2019 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 10/2019 - 01/2018
2	Angiotensin Receptor AntagonistsIBA 01/2019 - 01/2019
2	Tacrolimus (Prograf)FDA LinkGeneric 12/2017 - 07/2014
2	Anticonvulsants (Antiepileptic Drugs)IBA 11/2006 - 04/2003
1	NitratesIBA 12/2019
1	Hydralazine (Apresoline)FDA LinkGeneric 12/2019
1	TroponinIBA 10/2019
1	Mineralocorticoid Receptor AntagonistsIBA 01/2019
1	Everolimus FDA Link 12/2017
1	TOR Serine-Threonine KinasesIBA 12/2017
1	Interferon beta-1b (Betaseron)FDA Link 11/2014
1	Interferon beta-1a FDA Link 11/2014
1	InterferonsIBA 11/2014
1	Glatiramer Acetate (Copaxone)FDA Link 11/2014
1	Carbidopa (Lodosyn)FDA LinkGeneric 11/2011
1	entacapone (Comtan)FDA Link 11/2011
1	Levodopa (L Dopa)FDA LinkGeneric 11/2011
1	Therapeutic UsesIBA 01/2008
1	SodiumIBA 04/2003

Therapy/Procedure

10	Therapeutics 11/2019 - 07/2013
3	Injections 11/2014 - 09/2014
1	Patient Readmission 01/2020
1	Contraindications 01/2019
1	Cardiac Resynchronization Therapy 01/2018
1	Transplantation 12/2017
1	Liver Transplantation 12/2017
1	Immunomodulation 09/2014
1	Activities of Daily Living (ADL) 07/2013